Osteonecrosis of the jaw: More research needed

Journal of Bone and Mineral Research

Volumn 21, Issue 10, 2006, Pages 1503-1505

  Shane, Elizabeth ^a   Goldring, Steve ^b   Christakos, Sylvia ^c   Drezner, Marc ^d   Eisman, John ^e   Silverman, Stuart ^f   Pendrys, David ^g  

^a College of Physicians and Surgeons ^*  (United States)

^b HOSPITAL FOR SPECIAL SURGERY   (United States)

^c RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^e GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; IBANDRONIC ACID; NITROGEN DERIVATIVE; RISEDRONIC ACID; ZOLEDRONIC ACID;

BONE NECROSIS; CANCER PATIENT; CLINICAL STUDY; DENTAL SURGERY; DENTISTRY; DRUG MEGADOSE; EVIDENCE BASED MEDICINE; HEALTH CARE PERSONNEL; HUMAN; INCIDENCE; INTERDISCIPLINARY COMMUNICATION; JAW DISEASE; LOW DRUG DOSE; MEDICAL INFORMATICS; MEDICAL LITERATURE; MEDICAL RESEARCH; OSTEOPOROSIS; PAGET BONE DISEASE; PRACTICE GUIDELINE; REVIEW;

BIOMEDICAL RESEARCH; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; HUMANS; JAW; OSTEITIS DEFORMANS; OSTEONECROSIS; OSTEOPOROSIS;

EID: 33749234591     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.060712     Document Type: Review

References (17)

1. Woo SW, Hellstein JW, Kalmar J 2006 Bisphosphonates and osteonecrosis of the jaws: A position paper by the American Academy of Oral and Maxillofacial Pathology. Ann Intern Med 144:753-761.
2. Oltolina A, Achilli A, Lodi G, Demarosi F, Sardella 2005 Osteonecrosis of the jaws in patients treated with bisphosphonates. Review of the literature and the Milan experience. Minerva Stomatol 54:441-448.
3. Marx RE 2003 Pamidronate (Aredia) and zolendronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic. J Oral Maxillofac Surg 61:1115-1117.
4. Carter G, Goss AN, Doecke C 2005 Bisphosphonates and avascular necrosis of the jaw: A possible association. Med J Aust 182:413-415.
5. Chang J 2004 Food and Drug Administration Postmarketing Review. Available online at http://www.fda.gov/OHRMS/DOCKETS/ac/05/briefing/2005-4095B20304-FDA- TAB3.pdf.
6. Farrugia MC, Summerlin DJ, Krowiak E, Huntley T, Freeman S, Borrowdale R, Tomich C 2006 Osteonecrosis of the mandible or maxilla associated with the use of new generation bisphosphonates. Laryngoscope 116:115-120.
7. Hoefert S, Eufinger H 2005 Osteonecrosis of the jaws as a possible adverse effect of the use of bisphosphonates. Mund Kiefer Gesichtschir 9:233-238.
8. Hoefert S, Eufinger H 2005 Necrosis of the jaws under bisphosphonate therapy. Orthopade 35:204-210.
9. Marx RE, Sawatari Y, Fortin M, Broumand V 2005 Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: Risk factors, recognition, prevention and treatment. J Oral Maxillofac Surg 63:1567-1575.
10. Migliorati CA, Schubert MM, Peterson DE, Seneda LM 2005 Bisphosphonate associated osteonecrosis of the mandibulary and maxillary bone-an emerging oral complication of supportive cancer therapy. Cancer 104:83-93.
11. Najm SA, Lysitsa S, Carrel JP, Lesclous P, Lombardi T, Samson J 2005 Osteonecrose des maxillaries chez des patients traits par bisphosphonates. J Presse Med 34:1073-1077.
12. Purcell PM, Boyd IW 2005 Bisphosphonates and osteonecrosis of the jaw. Med J Aust 182:417-418.
13. Ruggiero SI, Mehrotra B, Rosenberg TJ, Engroff SL 2004 Osteonecrosis of the jaws associated with use of bisphosphonates: A review of 63 cases. J Oral Maxillofac Surg 62:527-534.
14. Starck WJ, Epker BN 1995 Failure of osseointegrated dental implants after diphosphonate therapy for osteoporosis: A case report. Int J Oral Maxillofac Implants 10:74-78.
15. Polizzotto MN, Cousins V, Schwarer AP 2006 Bisphosphonate-associated osteonecrosis of the auditory canal. Br J Haematol 132:114.
16. Medicines and Healthcare Products Regulatory Agency (MHRA) 2006 Committee on Safety of Medicines. Curr Probl Pharmacovigilance 31:4-5.
17. Council on Scientific Affairs of the American Dental Association Expert panel recommendations: Dental management of patients on oral bisphosphonate therapy. Available online at http://www.ada.org/prof/resources/topics/ topics_osteonecrosis_ recommendations.pdf. Accessed June 19, 2006.